New Rieck DSAEK insertion instrument

Article

Posterior lamellar keratoplasty with DSAEK is a new surgical technique for the treatment of endothelial corneal diseases.

Posterior lamellar keratoplasty with DSAEK is a new surgical technique for the treatment of endothelial corneal diseases. Advantages of DSAEK include faster rehabilitation and reduced astigmatism.

For a gentle insertion of the DSAEK donor tissue using the pull-through technique, Geuder has, in cooperation with Professor Peter Rieck of the Charité Eye Clinic in Berlin, developed a new DSAEK insertion instrument. The instrument's hinge design allows controlled folding of the donor tissue without overlapping or compression. During the surgical implantation procedure, the incision is kept open by the guiding plate, which also protects the tissue from being crushed while it is being pulled into the anterior chamber. The implantation procedure is suture-free and self-sealing.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.